Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$60,000,788
-$11,364,608 QoQ
Shares Held
1,102,753
-33.7% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. EXEL ranks #30 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,000,788 | 1,102,753 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $71,365,396 | 1,663,917 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $57,877,249 | 1,320,494 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $53,511,747 | 1,295,684 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $59,729,015 | 1,355,014 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $45,985,519 | 1,245,545 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $29,703,098 | 891,985 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $20,620,983 | 794,643 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $19,491,398 | 867,441 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,460,573 | 862,224 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,422,957 | 434,471 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,681,474 | 351,555 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,437,478 | 127,550 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,856,740 | 95,659 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,653,851 | 103,108 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,929,421 | 250,601 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $332,057 | 15,949 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $587,650 | 25,922 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $558,234 | 30,538 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $633,269 | 29,956 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $700,612 | 38,453 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,421,060 | 107,174 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,318,043 | 115,498 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $4,091,095 | 167,325 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,238,586 | 178,542 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,156,546 | 183,307 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||